![Ji-Hoon Sohn](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Ji-Hoon Sohn
Amministratore Delegato presso
PHARMARESEARCH CO., LTD.
Profilo
Ji-Hoon Sohn is currently Chief Executive Officer & Director at PharmaResearch Co., Ltd. since 2025.
Formerly, Mr. Sohn was President, Co-Chief Executive Officer & Director at DONG WHA PHARM Co., Ltd. Mr. Sohn was Chief Executive Officer & Executive Director at Hugel, Inc. from 2018 to 2024.
Education includes an MBA from Boston University conferred in 1988 and an undergraduate degree from Korea University.
Posizioni attive di Ji-Hoon Sohn
| Società | Posizione | Inizio |
|---|---|---|
| PHARMARESEARCH CO., LTD. | Amministratore Delegato | 25/03/2025 |
Precedenti posizioni note di Ji-Hoon Sohn
| Società | Posizione | Fine |
|---|---|---|
| HUGEL, INC. | Amministratore Delegato | - |
| DONGWHA PHARM.CO.,LTD | Amministratore Delegato | - |
Formazione di Ji-Hoon Sohn
Esperienze
Posizioni ricoperte
Attive
Inattive
Società nel listino
Aziende private
Relazioni
91
Relazioni di 1° grado
5
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Aziende private | 5 |
|---|---|
DONG WHA PHARM Co., Ltd.
 DONG WHA PHARM Co., Ltd. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical and medicinal chemicals | Health Technology |
Boston University
 Boston University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Korea University
 Korea University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Hugel, Inc.
 Hugel, Inc. BiotechnologyHealth Technology Manufactures and supplies toxin products, cosmetics, medical devices and pharmaceuticals | Health Technology |
PharmaResearch Co., Ltd.
 PharmaResearch Co., Ltd. Pharmaceuticals: MajorHealth Technology Engages in the research and development of refined raw materials for cell and tissue regeneration through marine bio technology | Health Technology |
